TickerFactsScreenerDevelopers

NeuroSense Therapeutics Ltd. (NRSNW) — Operating Income

Annual figures by fiscal year, from SEC filings.

2021: -$2.98M2022: -$10.55M2023: -$12.05M2024: -$9.90M2025: -$11.09M-$11.09M
2021Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$11.09M-11.9%
2024-$9.90M+17.8%
2023-$12.05M-14.2%
2022-$10.55M-253.6%
2021-$2.98M—